CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Comparative investigation of basal insulin glargine versus metformin as first line drug in patients with type 2 diabetes on B-Cell and endothelial function
DOI 10.1055/s-0032-1314591
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Pistrosch, F Schaper, M Hanefeld, T Forst, C Köhler, W Landgraf
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe05/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Metformin (MET) as first line drug fails to prevent disease progression. Early use of insulin might be able to preserve beta cell function. We compared effect on B-Cell function, endothelial function and cardiovascular risk factors. Open-label, randomized, prospective 36-wk study. 75 eligible drug naive patients (45/30m/f, age 60.7±9.2 yr), HbA1c between 6.5 & 8.5% were allocated to MET 1000mg b.i.d. (n=36) or insul…
Zitieren
Zitierempfehlung
F Pistrosch, F Schaper, M Hanefeld, T Forst, C Köhler, W Landgraf (2012) Comparative investigation of basal insulin glargine versus metformin as first line drug in patients with type 2 diabetes on B-Cell and endothelial function. Diabetologie und Stoffwechsel (05). https://doi.org/10.1055/s-0032-1314591
Mit CareLit weiterarbeiten